Key result
Resveratrol attenuates doxorubicin-induced renal cytotoxicity by preserving mitochondrial oxygen consumption.
Why the study?
The cellular mechanisms for doxorubicin mediated renal cytotoxicity have not been entirely identified and resveratrol may protect against this toxicity by maintaining mitochondrial function.
Does resveratrol prevent doxorubicin-induced cytotoxicity and mitochondrial dysfunction in human proximal tubular epithelial cells?
Does resveratrol prevent doxorubicin-induced cytotoxicity and mitochondrial dysfunction in human proximal tubular epithelial cells?
Resveratrol partially prevents doxorubicin-induced cytotoxicity and mitochondrial dysfunction in human renal proximal tubular epithelial cells in vitro.
Supports resveratrol mitochondrial protection in doxorubicin-exposed renal cells; hypothesis-generating and should not yet change practice.
The cancer chemotherapy agent Doxorubicin (DOX, Adriamycin), is FDA approved for use in the treatment regimen for acute lymphoid leukemia, breast, Hodgkin and Non‐Hodgkin lymphomas, small cell lung cancer and advanced non‐small cell lung cancer. Serious adverse effects include cardiomyopathy, congestive heart failure and renal dysfunction. The cellular mechanisms for doxorubicin mediated renal cytotoxicity have not been entirely identified. The trans‐stilbene resveratrol (RES) is a phytoalexin found in Japanese knotweed, grape skins, blueberries, cranberries, dark chocolate and nuts. Antioxidant and anticancer properties have been associated with RES in cell culture and in human clinical studies. Our studies examined RES protection for DOX renal cytotoxicity by maintaining mitochondrial function. All studies were conducted in human noncancerous renal proximal tubular epithelial cells (HK‐2). HK‐2 cells were plated and equilibrated for 48 h. Cells were next pre‐incubated for 1 h with 0 (DMSO) or up to 10 uM RES followed by a 24 h co‐incubation with 0‐5 uM DOX. All results were obtained from 3 independent experiments. Western analysis probed for protein carbonylation was used as an indicator of oxidative stress. Mitochondrial function was assessed using a Seahorse analyzer system. Prior to examining mitochondrial function, cell number and substrate concentrations were optimized. Mitochondrial Stress Test was conducted following the treatments described above and each well was normalized by protein. Viability was assessed using MTT leakage and trypan blue exclusion cell counts. RES did not alter cell viability as indicated by comparable MTT values between DMSO and RES groups (p>0.05). DOX was cytotoxic to HK‐2 cells within 24 h. Pretreatment with RES provided protection from DOX to HK‐2 cells. Basal mitochondrial respiration assessed as oxygen consumption rate (OCR) was diminished by 4 uM DOX. Mitophagy was probed using protein expression of LC3BI, LC3BII and the ratio of LC3BII/I following DOX exposure. In summary, RES attenuated DOX renal cytotoxicity by maintaining mitochondrial OCR near normal.
No takes yet. Share an insight, caveat, or question.
Valentovic et al. (2021) studied Doxorubicin-induced renal cytotoxicity. Resveratrol vs. DMSO (vehicle) was evaluated on Renal cytotoxicity and mitochondrial oxygen consumption rate. Pretreatment with resveratrol attenuated doxorubicin-induced renal cytotoxicity in human proximal tubular epithelial cells by maintaining mitochondrial oxygen consumption rate near normal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: